Medpace Holdings, Inc. Earnings

Medpace Holdings, Inc.’s revenue jumped 14.24% since last year same period to $603.31Mn in the Q2 2025. On a quarterly growth basis, Medpace Holdings, Inc. has generated 8.01% jump in its revenue since last 3-months.

Medpace Holdings, Inc.’s net profit jumped 2.16% since last year same period to $90.26Mn in the Q2 2025. On a quarterly growth basis, Medpace Holdings, Inc. has generated -21.24% fall in its net profits since last 3-months.

Medpace Holdings, Inc.’s net profit margin fell -10.57% since last year same period to 14.96% in the Q2 2025. On a quarterly growth basis, Medpace Holdings, Inc. has generated -27.08% fall in its net profit margins since last 3-months.

Medpace Holdings, Inc.’s price-to-earnings ratio after this Q2 2025 earnings stands at 35.73.

Medpace Holdings, Inc.’s earning per share (EPS) estimates for the current quarter stand at 3.47 - a 16.05% jump from last quarter’s estimates.

Medpace Holdings, Inc.’s earning per share (EPS) estimates for the current year stand at 3.47.

Medpace Holdings, Inc.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Medpace Holdings, Inc. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.